secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0001683168-22-008170
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences receives Nasdaq extension to May 29, 2023 to regain $1 bid price compliance
--------------------------------------------------------------------------------

- Nasdaq granted an additional 180 calendar days, until May 29, 2023, to meet the $1.00 minimum bid price requirement.
- Company previously notified of non-compliance on June 3, 2022; bid price below $1.00 for 30 consecutive business days.
- Eligibility based on meeting all other initial listing standards and written intent to cure via reverse stock split if needed.
- If bid price closes at $1.00+ for 10 consecutive days before May 29, 2023, compliance will be achieved.
- Failure to cure may lead to delisting, subject to appeal to a Nasdaq hearings panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822008170/0001683168-22-008170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316822008170/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer